ArticleMolecular cancer therapeutics2021

Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity.

James Harper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.